Exelixis

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Exelixis and other ETFs, options, and stocks.

About EXEL

Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic.

CEO

Michael M. Morrissey

CEOMichael M. Morrissey

Employees

1,310

Employees1,310

Headquarters

Alameda, California

HeadquartersAlameda, California

Founded

1994

Founded1994

Employees

1,310

Employees1,310

EXEL Key Statistics

Market cap

9.39B

Market cap9.39B

Price-Earnings ratio

20.95

Price-Earnings ratio20.95

Dividend yield

—

Dividend yield—

Average volume

2.99M

Average volume2.99M

High today

$36.66

High today$36.66

Low today

$32.73

Low today$32.73

Open price

$36.41

Open price$36.41

Volume

3.83M

Volume3.83M

52 Week high

$37.59

52 Week high$37.59

52 Week low

$20.02

52 Week low$20.02

EXEL News

TipRanks 16h

Jefferies has two ‘contradictory’ conclusions after Exelixis abstract release

After the American Society of Clinical Oncology released an abstract on data for zanzalintinib alone or in combination with atezolizumab in patients with refrac...

Simply Wall St 6d

Institutional investors control 74% of Exelixis, Inc. and were rewarded last week after stock increased 5.9%

Key Insights Significantly high institutional ownership implies Exelixis' stock price is sensitive to their trading actions A total of 10 investors have a maj...

Analyst ratings

57%

of 23 ratings

Buy

56.5%

Hold

34.8%

Sell

8.7%